| # | Drug | Count |
|---|---|---|
| 0 | UPADACITINIB | 97 |
| 1 | ATORVASTATIN CALCIUM | 84 |
| 2 | LORLATINIB | 83 |
| 3 | METHOTREXATE SODIUM | 82 |
| 4 | ASPIRIN | 72 |
| 5 | ASPIRIN 325 MG | 71 |
| 6 | ASPIRIN 81 MG | 71 |
| 7 | METHOTREXATE | 68 |
| 8 | ADALIMUMAB | 64 |
| 9 | ISOTRETINOIN | 63 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PROCAINAMIDE HYDROCHLORIDE | 4 | 0.0162 |
| 1 | HUMAN GROWTH HORMONE | 1 | 0.0143 |
| 2 | LORLATINIB | 83 | 0.0111 |
| 3 | NIPOCALIMAB-AAHU | 3 | 0.0094 |
| 4 | ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE | 1 | 0.0076 |
| 5 | ABROCITINIB | 27 | 0.0068 |
| 6 | ERYTHROMYCIN AND BENZOYL PEROXIDE | 1 | 0.0062 |
| 7 | AURANOFIN | 1 | 0.0049 |
| 8 | DIFLUPREDNATE OPHTHALMIC | 4 | 0.0045 |
| 9 | RITLECITINIB | 8 | 0.0041 |
| # | Drug class | Count |
|---|---|---|
| 0 | Janus Kinase Inhibitor [EPC] | 162 |
| 1 | Atypical Antipsychotic [EPC] | 161 |
| 2 | Kinase Inhibitor [EPC] | 161 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 126 |
| 4 | HMG-CoA Reductase Inhibitor [EPC] | 118 |
| 5 | Corticosteroid [EPC] | 115 |
| 6 | Retinoid [EPC] | 84 |
| 7 | PCSK9 Inhibitor [EPC] | 80 |
| 8 | Benzodiazepine [EPC] | 79 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 72 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | PCSK9 Inhibitor [EPC] | 80 | 0.0031 |
| 1 | Leptin Analog [EPC] | 3 | 0.0024 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 4 | 0.0019 |
| 3 | Provitamin D2 Compound [EPC] | 47 | 0.0016 |
| 4 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 5 | CCR5 Co-receptor Antagonist [EPC] | 3 | 0.0013 |
| 6 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 25 | 0.0010 |
| 7 | Protease Inhibitor [EPC] | 45 | 0.0010 |
| 8 | Janus Kinase Inhibitor [EPC] | 162 | 0.0010 |
| 9 | Cytochrome P450 3A Inhibitor [EPC] | 53 | 0.0009 |